HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a spinal technology company focused on autologous regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the publication of its research completed with Rice University, titled, “Chondrogenic Differentiation of Neonatal Human Dermal Fibroblasts Encapsulated in Alginate Beads with Hydrostatic Compression Under Hypoxic Conditions in the Presence of Bone Morphogenetic Protein-2”. Published in the June 2011 issue of Journal of Biomedical Materials Research, the research provides validation of SpinalCyte’s core technology to regrow the spinal disc, using human dermal fibroblasts. The research was conducted over a 2 year period under the direction of acclaimed researcher, Antonios Mikos, Ph.D. at Rice University’s Department of Bioengineering. Using intermittent hydrostatic pressure, the dermal cells were successfully differentiated into cartilage type cells necessary to regrow the nucleus pulposus.
